张璐
合伙人 at Addor Capital
About
张璐, trained at China Pharmaceutical University, focuses on small nucleic acid drugs, cell and gene therapies and mRNA, taking a hands-on, mechanism- and clinical-pathway-driven approach to build CDMO/drug-platform partnerships.
Invests in
BiotechClimate TechDeep TechHardwareHealthtechNew Materials